SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-100863
Filing Date
2024-04-18
Accepted
2024-04-18 16:44:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d774808ds3.htm S-3 216898
2 EX-5.1 d774808dex51.htm EX-5.1 13515
3 EX-23.1 d774808dex231.htm EX-23.1 2336
4 EX-FILING FEES d774808dexfilingfees.htm EX-FILING FEES 18845
5 GRAPHIC g774808g0417081235161.jpg GRAPHIC 3252
6 GRAPHIC g774808g0417121449602.jpg GRAPHIC 1414
7 GRAPHIC g774808g08l03.jpg GRAPHIC 28909
8 GRAPHIC g774808g47r84.jpg GRAPHIC 41618
  Complete submission text file 0001193125-24-100863.txt   356736
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278801 | Film No.: 24854817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)